3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Parathyroid Neoplasms
1
Neovascularization, Pathologic
1
Hyperparathyroidism, Primary
1
Carcinoma, Renal Cell
1
Interventions
fluorocholine
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Standard of Care
1
Specimen Handling
1
Rubidium-82
1
Ipilimumab
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parathyroid Neoplasms
×
Rubidium-82
×
1 year
×
Clear all
NCT07099404
2025-08-22
PARAGON
Montreal Heart Institute
Not yet recruiting
20 enrolled